The use of nanoparticles is revolutionizing the way we approach heart disease, offering more targeted and effective treatments. Nanotechnology and cardiovascular medicine are becoming increasingly intertwined, providing innovative solutions for drug delivery systems that directly target affected areas of the heart. By minimizing side effects and increasing the efficacy of treatments, these advances hold significant promise. Additionally, nanotechnology is improving diagnostic capabilities, allowing for earlier detection of cardiovascular conditions with greater accuracy. As research in nanomedicine continues to progress, it opens up exciting possibilities for tissue regeneration and the development of artificial blood vessels, offering hope for those with chronic cardiovascular issues.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India